{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:53:22Z","timestamp":1780401202503,"version":"3.54.1"},"reference-count":26,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hypothyroidism is a frequent disease, and oral levothyroxine is the mainstay of its treatment. However, more than 15% of levothyroxine-treated patients fail to achieve the recommended serum TSH level, and \u201crefractory hypothyroidism\u201d is due to either malabsorption, increased metabolism of thyroxine, or nonadherence to treatment. A levothyroxine absorption test must be used to differentiate true malabsorption from nonadherence or pseudo-malabsorption.<\/jats:p>\n               <jats:p>We analyzed 166 levothyroxine absorption tests in 143 hypothyroid patients (109 women, mean age 43 \u00b1 1 years) treated with oral levothyroxine. Despite a daily dose of 3.26 \u00b1 0.09\u2005\u00b5g\/kg\/day, mean serum TSH concentration was 25.7 \u00b1 3.7\u2005mU\/L. \u201cRefractory hypothyroidism\u201d was in the context of gastritis (24%), Helicobacter pylori infection (18%), drug interference with levothyroxine absorption (15.6%), nonadherence to treatment (10%), celiac disease (2.5%), or bariatric surgery (1.2%). After an overnight fast, patients orally took their daily dose of levothyroxine (220 \u00b1 6\u2005\u00b5g), and blood samples were drawn before levothyroxine intake and every 2 hours for 24\u2005hours.<\/jats:p>\n               <jats:p>After levothyroxine intake, the mean total (basal = 7.64 \u00b1 0.26\u2005\u00b5g\/dL, peak 9.41 \u00b1 0.28\u2005\u00b5g\/dL), and free (basal = 12.58 \u00b1 0.42\u2005pg\/mL, peak 15.77 \u00b1 0.51\u2005pg\/mL) T4 levels increased (P &amp;lt; .001), total and free T4 peaks were observed at 4.2 \u00b1 0.23 and 4.30 \u00b1 9.27\u2005hours, respectively. Levothyroxine absorption tests were well tolerated.<\/jats:p>\n               <jats:p>In conclusion, in most patients with \u201crefractory hypothyroidism,\u201d this clinical study revealed that the levothyroxine absorption test can be achieved via the absorption of the daily dosage of levothyroxine, and the evaluation of total or free T4 concentrations over 4- or 6-hour follow-up. The test is well tolerated without cardiovascular adverse events.<\/jats:p>","DOI":"10.1210\/jendso\/bvaf017","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:34:46Z","timestamp":1741134886000},"source":"Crossref","is-referenced-by-count":7,"title":["Levothyroxine Absorption Test With the Daily Levothyroxine Dose in Patients With \u201cRefractory Hypothyroidism\u201d"],"prefix":"10.1210","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5391-7582","authenticated-orcid":false,"given":"Philippe","family":"Caron","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Metabolic Diseases and Nutrition, Cardiovascular and Metabolic Unit, CHU Larrey , 31059 Toulouse ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Tudor","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolic Diseases and Nutrition, Cardiovascular and Metabolic Unit, CHU Larrey , 31059 Toulouse ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6174-448X","authenticated-orcid":false,"given":"Solange","family":"Grunenwald","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolic Diseases and Nutrition, Cardiovascular and Metabolic Unit, CHU Larrey , 31059 Toulouse ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"issue":"1","key":"2025052712290430800_bvaf017-B1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1210\/er.2018-00168","article-title":"Gastrointestinal malabsorption of thyroxine","volume":"40","author":"Virili","year":"2019","journal-title":"Endocr Rev"},{"issue":"2","key":"2025052712290430800_bvaf017-B2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.clinthera.2017.01.005","article-title":"2017 factors affecting gastrointestinal absorption of levothyroxine: a review","volume":"39","author":"Skelin","year":"2017","journal-title":"Clin Ther"},{"issue":"12","key":"2025052712290430800_bvaf017-B3","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s40618-017-0706-y","article-title":"Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report","volume":"40","author":"Centanni","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"2025052712290430800_bvaf017-B4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fendo.2017.00155","article-title":"Refractory hypothyroidism due to improper storage of levothyroxine tablets","volume":"8","author":"Benvenga","year":"2017","journal-title":"Front Endocrinol"},{"issue":"12","key":"2025052712290430800_bvaf017-B5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.eprac.2023.09.003","article-title":"Refractory hypothyroidism: unraveling the complexities of diagnosis and management","volume":"29","author":"Quiroz-Aldave","year":"2023","journal-title":"Endocr Pract"},{"issue":"1","key":"2025052712290430800_bvaf017-B6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/ct.2020;32.6-8","article-title":"A report of the mayo clinic experience on the levothyroxine ab- sorption test","volume":"32","author":"Biondi","year":"2020","journal-title":"Clin Thyroidol"},{"issue":"4","key":"2025052712290430800_bvaf017-B7","first-page":"e37776","article-title":"Validity of the rapid thyroxine absorption test for the differentiation between levothyroxine non-compliance and malabsorption in thyroid-stimulating hormone refractory hypothyroidism","volume":"15","author":"Alhassan","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"2025052712290430800_bvaf017-B8","doi-asserted-by":"crossref","first-page":"e31051","DOI":"10.5812\/ijem.31051","article-title":"Rapid levothyroxine absorption testing: a case series of nonadherent patients","volume":"13","author":"Balla","year":"2015","journal-title":"Int J Endocrinol Metab"},{"issue":"5","key":"2025052712290430800_bvaf017-B9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/cen.14902","article-title":"Levothyroxine absorption test: a therapeutic strategy for improving medication adherence","volume":"98","author":"Barbar","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2025052712290430800_bvaf017-B10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000504218","article-title":"Levothyroxine absorption test to differentiate pseudomalabsorption from true malabsorption","volume":"9","author":"Ghosh","year":"2020","journal-title":"Eur Thyroid J"},{"issue":"12","key":"2025052712290430800_bvaf017-B11","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1089\/thy.2019.0256","article-title":"The levothyroxine absorption test: a four-year experience (2015-2018) at the Mayo Clinic","volume":"29","author":"Gonzales","year":"2019","journal-title":"Thyroid"},{"issue":"1","key":"2025052712290430800_bvaf017-B12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13044-015-0028-0","article-title":"A single bolus of high dose levothyroxine (L-T4) as a test in cases of suspected poor compliance to L-T4 therapy","volume":"8","author":"Lewandowski","year":"2015","journal-title":"Thyroid Res"},{"issue":"1","key":"2025052712290430800_bvaf017-B13","first-page":"1083","article-title":"Rapid levothyroxine (lt4) absorption test for diagnosis of LT4 pseudomalabsorption: case report and proposal of a cutoff point","volume":"4","author":"Soares","year":"2016","journal-title":"J Endocrinol Diabetes Obes"},{"issue":"9","key":"2025052712290430800_bvaf017-B14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.29271\/jcpsp.2021.09.1099","article-title":"Diagnosis of levothyroxine Pseudo-malabsorption: the results of standardised testing protocol","volume":"31","author":"S\u00f6zen","year":"2021","journal-title":"J Coll Physicians Surg Pak"},{"issue":"1","key":"2025052712290430800_bvaf017-B15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/ijem.ijem_188_21","article-title":"Levothyroxine absorption test\u2014results and follow up of patients from a single center","volume":"27","author":"Subramaniam","year":"2023","journal-title":"Indian J Endocrinol Metab"},{"issue":"9","key":"2025052712290430800_bvaf017-B16","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4158\/EP13487.OR","article-title":"The clinical utility of free thyroxine in oral levothyroxine absorption testing","volume":"20","author":"Sun","year":"2014","journal-title":"Endocr Pract"},{"issue":"6","key":"2025052712290430800_bvaf017-B17","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1530\/EJE-12-1035","article-title":"A thyroxine absorption test followed by weekly thyroxine administration: a method to assess non-adherence to treatment","volume":"168","author":"Walker","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2025052712290430800_bvaf017-B18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4183\/aeb.2022.375","article-title":"Severe refractory hypothyroidism in a 48-year-old female: role of low-dose thyroxine absorption test in establishing diagnosis of non-compliance","volume":"18","author":"Younes","year":"2022","journal-title":"Acta Endocrinol (Buchar)"},{"key":"2025052712290430800_bvaf017-B19","first-page":"A83","article-title":"1981 development of a non-isotopic method for determination of oral T4 absorption","volume":"29","author":"Greenstadt","year":"1981","journal-title":"Clin Res"},{"issue":"8","key":"2025052712290430800_bvaf017-B20","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1210\/clinem\/dgad132","article-title":"The use of levothyroxine absorption tests in clinical practice","volume":"108","author":"Caron","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025052712290430800_bvaf017-B21","doi-asserted-by":"crossref","first-page":"e220355","DOI":"10.1530\/EC-22-0355","article-title":"Levothyroxine malabsorption or pseudomalabsorption? A question in the management of refractory hypothyroidism","volume":"11","author":"Santos Monteiro","year":"2022","journal-title":"Endocr Connect"},{"issue":"1","key":"2025052712290430800_bvaf017-B22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13256-023-03760-0","article-title":"Levothyroxine absorption test followed by directly observed treatment on an outpatient basis to address long-term high thyrotropin levels in a hypothyroid patient: a case report","volume":"17","author":"Kiran","year":"2023","journal-title":"J Med Case Rep"},{"issue":"6","key":"2025052712290430800_bvaf017-B23","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ando.2007.09.003","article-title":"Pseudomalabsorption of thyroid hormones: case report and review of the literature","volume":"68","author":"Livadariu","year":"2007","journal-title":"Ann Endocrinol (Paris)"},{"issue":"6","key":"2025052712290430800_bvaf017-B24","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1365-2265.2007.02975.x","article-title":"In vivo evidence for a direct ultra-fast negative feedback of thyroxine on TSH secretion in humans: a case of L-thyroxine pseudomalabsorption","volume":"67","author":"Goichot","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025052712290430800_bvaf017-B25","doi-asserted-by":"crossref","first-page":"621616","DOI":"10.3389\/fendo.2020.621616","article-title":"Levothyroxine therapy in gastric malabsorptive disorders","volume":"11","author":"Virili","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2025052712290430800_bvaf017-B26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1523-5378.2011.00830.x","article-title":"The role of Helicobacter pylori in patients with hypothyroidism in whom could not be achieved normal thyrotropin levels despite treatment with high doses of thyroxine","volume":"16","author":"Bugdaci","year":"2011","journal-title":"Helicobacter"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/9\/4\/bvaf017\/62261611\/bvaf017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/9\/4\/bvaf017\/62261611\/bvaf017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:29:18Z","timestamp":1748363358000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvaf017\/8051410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3,3]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvaf017","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,3,3]]},"article-number":"bvaf017"}}